A recent study published in the journal Scientific Reports and available online through the National Library of Medicine has revealed promising results for the use of cannabidiol (CBD) in treating hand osteoarthritis (OA).
Conducted by researchers at the University of Sydney, Avecho Biotechnology, and the NTF Group in Australia, the study explored the potential benefits of a novel transdermal CBD gel for managing this chronic condition.
Hand OA is a degenerative disease characterized by chronic pain and impaired functionality, and current treatment options often fall short. CBD has previously demonstrated analgesic and anti-inflammatory effects in preclinical arthritis models, prompting researchers to investigate its efficacy in human subjects.
Continue reading